Report Detail
Global Liver Cancer Treatment Drug Market Growth (Status and Outlook) 2022-2028
- RnM4496128 |
- 01 December, 2022 |
- Global |
- 110 Pages |
- LPI(LP Information) |
- Medical Industry
The global market for Liver Cancer Treatment Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Liver Cancer Treatment Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Liver Cancer Treatment Drug players cover 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG and Becton, Dickinson and Co., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Liver Cancer Treatment Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Liver Cancer Treatment Drug market, with both quantitative and qualitative data, to help readers understand how the Liver Cancer Treatment Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Liver Cancer Treatment Drug market and forecasts the market size by Type (Targeted Therapy, Radiation Therapy and Immunotherapy), by Application (Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other
Segmentation by application
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
4SC AG
Alnylam Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc
Bayer AG
Becton, Dickinson and Co.
Bristol-Myers Squibb Co.
Celsion Corp.
Dicerna Pharmaceuticals, Inc.
Eli Lilly and Co.
Exelixis, Inc.
F. Hoffmann-La Roche, Ltd.
FibroGen, Inc.
General Electric Co.(GE Healthcare)
Merck & Co., Inc.(ArQule, Inc.)
Novartis International AG
Nymox Corp.
Pfizer, Inc.
SMC Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Chapter Introduction
Chapter 1: Scope of Liver Cancer Treatment Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Liver Cancer Treatment Drug market size and CAGR, Liver Cancer Treatment Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Liver Cancer Treatment Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Liver Cancer Treatment Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Liver Cancer Treatment Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG, Becton, Dickinson and Co., Bristol-Myers Squibb Co., Celsion Corp., Dicerna Pharmaceuticals, Inc. and Eli Lilly and Co., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Liver Cancer Treatment Drug Market Size 2017-2028
- 2.1.2 Liver Cancer Treatment Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Liver Cancer Treatment Drug Segment by Type
- 2.2.1 Targeted Therapy
- 2.2.2 Radiation Therapy
- 2.2.3 Immunotherapy
- 2.2.4 Chemotherapy
- 2.2.5 Other
- 2.3 Liver Cancer Treatment Drug Market Size by Type
- 2.3.1 Liver Cancer Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Liver Cancer Treatment Drug Market Size Market Share by Type (2017-2022)
- 2.4 Liver Cancer Treatment Drug Segment by Application
- 2.4.1 Hepatocellular Carcinoma
- 2.4.2 Cholangio Carcinoma
- 2.4.3 Hepatoblastoma
- 2.4.4 Other
- 2.5 Liver Cancer Treatment Drug Market Size by Application
- 2.5.1 Liver Cancer Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Liver Cancer Treatment Drug Market Size Market Share by Application (2017-2022)
3 Liver Cancer Treatment Drug Market Size by Player
- 3.1 Liver Cancer Treatment Drug Market Size Market Share by Players
- 3.1.1 Global Liver Cancer Treatment Drug Revenue by Players (2020-2022)
- 3.1.2 Global Liver Cancer Treatment Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Liver Cancer Treatment Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Liver Cancer Treatment Drug by Regions
- 4.1 Liver Cancer Treatment Drug Market Size by Regions (2017-2022)
- 4.2 Americas Liver Cancer Treatment Drug Market Size Growth (2017-2022)
- 4.3 APAC Liver Cancer Treatment Drug Market Size Growth (2017-2022)
- 4.4 Europe Liver Cancer Treatment Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Liver Cancer Treatment Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Liver Cancer Treatment Drug Market Size by Country (2017-2022)
- 5.2 Americas Liver Cancer Treatment Drug Market Size by Type (2017-2022)
- 5.3 Americas Liver Cancer Treatment Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Liver Cancer Treatment Drug Market Size by Region (2017-2022)
- 6.2 APAC Liver Cancer Treatment Drug Market Size by Type (2017-2022)
- 6.3 APAC Liver Cancer Treatment Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Liver Cancer Treatment Drug by Country (2017-2022)
- 7.2 Europe Liver Cancer Treatment Drug Market Size by Type (2017-2022)
- 7.3 Europe Liver Cancer Treatment Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Liver Cancer Treatment Drug by Region (2017-2022)
- 8.2 Middle East & Africa Liver Cancer Treatment Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Liver Cancer Treatment Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Liver Cancer Treatment Drug Market Forecast
- 10.1 Global Liver Cancer Treatment Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Liver Cancer Treatment Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Liver Cancer Treatment Drug Forecast
- 10.1.3 APAC Liver Cancer Treatment Drug Forecast
- 10.1.4 Europe Liver Cancer Treatment Drug Forecast
- 10.1.5 Middle East & Africa Liver Cancer Treatment Drug Forecast
- 10.2 Americas Liver Cancer Treatment Drug Forecast by Country (2023-2028)
- 10.2.1 United States Liver Cancer Treatment Drug Market Forecast
- 10.2.2 Canada Liver Cancer Treatment Drug Market Forecast
- 10.2.3 Mexico Liver Cancer Treatment Drug Market Forecast
- 10.2.4 Brazil Liver Cancer Treatment Drug Market Forecast
- 10.3 APAC Liver Cancer Treatment Drug Forecast by Region (2023-2028)
- 10.3.1 China Liver Cancer Treatment Drug Market Forecast
- 10.3.2 Japan Liver Cancer Treatment Drug Market Forecast
- 10.3.3 Korea Liver Cancer Treatment Drug Market Forecast
- 10.3.4 Southeast Asia Liver Cancer Treatment Drug Market Forecast
- 10.3.5 India Liver Cancer Treatment Drug Market Forecast
- 10.3.6 Australia Liver Cancer Treatment Drug Market Forecast
- 10.4 Europe Liver Cancer Treatment Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Liver Cancer Treatment Drug Market Forecast
- 10.4.2 France Liver Cancer Treatment Drug Market Forecast
- 10.4.3 UK Liver Cancer Treatment Drug Market Forecast
- 10.4.4 Italy Liver Cancer Treatment Drug Market Forecast
- 10.4.5 Russia Liver Cancer Treatment Drug Market Forecast
- 10.5 Middle East & Africa Liver Cancer Treatment Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Liver Cancer Treatment Drug Market Forecast
- 10.5.2 South Africa Liver Cancer Treatment Drug Market Forecast
- 10.5.3 Israel Liver Cancer Treatment Drug Market Forecast
- 10.5.4 Turkey Liver Cancer Treatment Drug Market Forecast
- 10.5.5 GCC Countries Liver Cancer Treatment Drug Market Forecast
- 10.6 Global Liver Cancer Treatment Drug Forecast by Type (2023-2028)
- 10.7 Global Liver Cancer Treatment Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 4SC AG
- 11.1.1 4SC AG Company Information
- 11.1.2 4SC AG Liver Cancer Treatment Drug Product Offered
- 11.1.3 4SC AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 4SC AG Main Business Overview
- 11.1.5 4SC AG Latest Developments
- 11.2 Alnylam Pharmaceuticals, Inc.
- 11.2.1 Alnylam Pharmaceuticals, Inc. Company Information
- 11.2.2 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product Offered
- 11.2.3 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Alnylam Pharmaceuticals, Inc. Main Business Overview
- 11.2.5 Alnylam Pharmaceuticals, Inc. Latest Developments
- 11.3 AVEO Pharmaceuticals, Inc
- 11.3.1 AVEO Pharmaceuticals, Inc Company Information
- 11.3.2 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product Offered
- 11.3.3 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 AVEO Pharmaceuticals, Inc Main Business Overview
- 11.3.5 AVEO Pharmaceuticals, Inc Latest Developments
- 11.4 Bayer AG
- 11.4.1 Bayer AG Company Information
- 11.4.2 Bayer AG Liver Cancer Treatment Drug Product Offered
- 11.4.3 Bayer AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Bayer AG Main Business Overview
- 11.4.5 Bayer AG Latest Developments
- 11.5 Becton, Dickinson and Co.
- 11.5.1 Becton, Dickinson and Co. Company Information
- 11.5.2 Becton, Dickinson and Co. Liver Cancer Treatment Drug Product Offered
- 11.5.3 Becton, Dickinson and Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Becton, Dickinson and Co. Main Business Overview
- 11.5.5 Becton, Dickinson and Co. Latest Developments
- 11.6 Bristol-Myers Squibb Co.
- 11.6.1 Bristol-Myers Squibb Co. Company Information
- 11.6.2 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product Offered
- 11.6.3 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Bristol-Myers Squibb Co. Main Business Overview
- 11.6.5 Bristol-Myers Squibb Co. Latest Developments
- 11.7 Celsion Corp.
- 11.7.1 Celsion Corp. Company Information
- 11.7.2 Celsion Corp. Liver Cancer Treatment Drug Product Offered
- 11.7.3 Celsion Corp. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Celsion Corp. Main Business Overview
- 11.7.5 Celsion Corp. Latest Developments
- 11.8 Dicerna Pharmaceuticals, Inc.
- 11.8.1 Dicerna Pharmaceuticals, Inc. Company Information
- 11.8.2 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product Offered
- 11.8.3 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Dicerna Pharmaceuticals, Inc. Main Business Overview
- 11.8.5 Dicerna Pharmaceuticals, Inc. Latest Developments
- 11.9 Eli Lilly and Co.
- 11.9.1 Eli Lilly and Co. Company Information
- 11.9.2 Eli Lilly and Co. Liver Cancer Treatment Drug Product Offered
- 11.9.3 Eli Lilly and Co. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Eli Lilly and Co. Main Business Overview
- 11.9.5 Eli Lilly and Co. Latest Developments
- 11.10 Exelixis, Inc.
- 11.10.1 Exelixis, Inc. Company Information
- 11.10.2 Exelixis, Inc. Liver Cancer Treatment Drug Product Offered
- 11.10.3 Exelixis, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Exelixis, Inc. Main Business Overview
- 11.10.5 Exelixis, Inc. Latest Developments
- 11.11 F. Hoffmann-La Roche, Ltd.
- 11.11.1 F. Hoffmann-La Roche, Ltd. Company Information
- 11.11.2 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product Offered
- 11.11.3 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
- 11.11.5 F. Hoffmann-La Roche, Ltd. Latest Developments
- 11.12 FibroGen, Inc.
- 11.12.1 FibroGen, Inc. Company Information
- 11.12.2 FibroGen, Inc. Liver Cancer Treatment Drug Product Offered
- 11.12.3 FibroGen, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 FibroGen, Inc. Main Business Overview
- 11.12.5 FibroGen, Inc. Latest Developments
- 11.13 General Electric Co.(GE Healthcare)
- 11.13.1 General Electric Co.(GE Healthcare) Company Information
- 11.13.2 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product Offered
- 11.13.3 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 General Electric Co.(GE Healthcare) Main Business Overview
- 11.13.5 General Electric Co.(GE Healthcare) Latest Developments
- 11.14 Merck & Co., Inc.(ArQule, Inc.)
- 11.14.1 Merck & Co., Inc.(ArQule, Inc.) Company Information
- 11.14.2 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product Offered
- 11.14.3 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Merck & Co., Inc.(ArQule, Inc.) Main Business Overview
- 11.14.5 Merck & Co., Inc.(ArQule, Inc.) Latest Developments
- 11.15 Novartis International AG
- 11.15.1 Novartis International AG Company Information
- 11.15.2 Novartis International AG Liver Cancer Treatment Drug Product Offered
- 11.15.3 Novartis International AG Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Novartis International AG Main Business Overview
- 11.15.5 Novartis International AG Latest Developments
- 11.16 Nymox Corp.
- 11.16.1 Nymox Corp. Company Information
- 11.16.2 Nymox Corp. Liver Cancer Treatment Drug Product Offered
- 11.16.3 Nymox Corp. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Nymox Corp. Main Business Overview
- 11.16.5 Nymox Corp. Latest Developments
- 11.17 Pfizer, Inc.
- 11.17.1 Pfizer, Inc. Company Information
- 11.17.2 Pfizer, Inc. Liver Cancer Treatment Drug Product Offered
- 11.17.3 Pfizer, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Pfizer, Inc. Main Business Overview
- 11.17.5 Pfizer, Inc. Latest Developments
- 11.18 SMC Laboratories, Inc.
- 11.18.1 SMC Laboratories, Inc. Company Information
- 11.18.2 SMC Laboratories, Inc. Liver Cancer Treatment Drug Product Offered
- 11.18.3 SMC Laboratories, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 SMC Laboratories, Inc. Main Business Overview
- 11.18.5 SMC Laboratories, Inc. Latest Developments
- 11.19 Thermo Fisher Scientific, Inc.
- 11.19.1 Thermo Fisher Scientific, Inc. Company Information
- 11.19.2 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product Offered
- 11.19.3 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Thermo Fisher Scientific, Inc. Main Business Overview
- 11.19.5 Thermo Fisher Scientific, Inc. Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Liver Cancer Treatment Drug . Industry analysis & Market Report on Liver Cancer Treatment Drug is a syndicated market report, published as Global Liver Cancer Treatment Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Liver Cancer Treatment Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
